Atnaujinkite slapukų nuostatas

El. knyga: Nonclinical Study Contracting and Monitoring: A Practical Guide

Edited by (PhD, DABT, PMP, PAREXEL International, Benton, AR), Edited by (BS, RQAP-GLP, Director of the Quality Assurance Unit, National Center for Toxicological Research, FDA, Jefferson, AR), Edited by (BS, LAT, Director of the Quality Assurance Unit, National Cent)
  • Formatas: EPUB+DRM
  • Išleidimo metai: 31-Dec-2012
  • Leidėjas: Academic Press Inc
  • Kalba: eng
  • ISBN-13: 9780123978318
  • Formatas: EPUB+DRM
  • Išleidimo metai: 31-Dec-2012
  • Leidėjas: Academic Press Inc
  • Kalba: eng
  • ISBN-13: 9780123978318

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Nonclinical Study Contracting and Monitoring: A Practical Guide offers a systematic and straightforward handbook for obtaining high quality preclinical Good Laboratory Practice (GLP) studies. This book is full of real-world examples, processes, procedures, useful templates, checklists and sample reports to provide readers with a better understanding of exactly what happens during all stages of a GLP study and the critical aspects of GLP study design and conduct. Designed for both the novice and experienced scientist, this book covers the GLP regulations and how they impact preclinical studies, the differences between GLP, non-GLP and peer-reviewed studies, preclinical GLP study design, laboratory selection, contracts and business ethics, how to obtain test material for the study, animal sourcing and release for study, preparation of a draft report and much more. By illustrating the overall big picture and tying it together with the individual steps, this book is an essential resource to help scientists ensure a high quality GLP study that passes both scientific and regulatory scrutiny.

  • Includes both the "big picture" look at complex processes, such as contracting toxicology and safety studies with CROs, as well as a detailed account of each individual step.
  • Contains several real world examples of problems in preclinical studies to provide you with an idea of the types of challenges that are routinely encountered and how this book can help you avoid these issues.
  • Provides monitoring checklists through the book that will help you comply with each GLP requirement and maintain compliance throughout the entire process.
  • Both entry level and experienced scientists involved in nonclinical toxicology study monitoring will benefit from the ideas, examples, discussions and strategies presented throughout this book.

Recenzijos

"I particularly liked the detailed checklists that are provided throughout the bookthis book is an excellent practical guide on how to perform, contract, monitor and report nonclinical studies.  It is well presented and easy to read and will be particularly useful for beginning study monitors and toxicologists." --British Toxicology Society, Issue 43, Winter 2013

Daugiau informacijos

A hands-on guide complete with checklists, practical examples and sample reports to assist readers with the challenges of ensuring high-quality GLP studies.
List of Contributors
xi
1 Introduction
1(18)
GLPs and Nonclinical Studies
4(2)
CROs and Nonclinical Studies
6(2)
Study Directors
8(1)
Examples of Study Issues
9(8)
General Study Issues
9(1)
Protocol
10(2)
Test Article
12(1)
In-Life
13(2)
Necropsy
15(1)
Reporting
16(1)
Conclusion
17(2)
2 Good Laboratory Practices
19(40)
US FDA (21 CFR Part 58) and OECD GLPs
22(1)
Subpart A General Provisions
23(2)
Section 58.3 (Definitions)
23(2)
Section 58.10 (Applicability to Studies Performed Under Grants and Contracts)
25(1)
Section 58.15 (Inspection of a Testing Facility)
25(1)
Subpart B Organization and Personnel
25(4)
Section 58.29 (Personnel)
26(1)
Computer Systems (21 CFR Part 11)
26(1)
Section 58.31 (Testing Facility Management)
26(1)
Section 58.33 (Study Director)
27(1)
Section 58.35 (QAU)
27(2)
Subpart C Facilities
29(1)
Section 58.41 (General)
29(1)
Section 58.43 (Animal Care Facilities)
29(1)
Section 58.45 (Animal Supply Facilities)
30(1)
Section 58.47 (Facilities for Handling Test and Control Articles)
30(1)
Section 58.49 (Laboratory Operation Areas)
30(1)
Section 58.51 (Specimen and Data Storage Facilities)
30(1)
Subpart D Equipment
30(1)
Section 58.61 (Equipment Design)
30(1)
Section 58.63 (Maintenance and Calibration of Equipment)
31(1)
Computer Systems (21 CFR Part 11)
31(1)
Subpart E Testing Facilities Operation
31(3)
Section 58.81 (Standard Operating Procedures [ SOPs])
31(1)
Section 58.83 (Reagents and Solutions)
32(1)
Section 58.90 (Animal Care)
33(1)
Subpart F Test and Control Articles
34(1)
Section 58.105 (Test and Control Article Characterization)
34(1)
Section 58.107 (Test and Control Article Handling)
34(1)
Section 58.113 (Mixtures of Articles with Carriers)
35(1)
Subpart G Protocol for and Conduct of a Nonclinical Laboratory Study
35(2)
Section 58.120 (Protocol)
35(1)
Section 58.130 (Conduct of a Nonclinical Laboratory Study)
36(1)
Subpart J Records and Reports
37(3)
Section 58.185 (Reporting of Nonclinical Laboratory Study Results)
37(1)
Section 58.190 (Storage and Retrieval of Records and Data)
38(1)
Section 58.195 (Retention of Records)
38(2)
GLP Facility Inspections
40(2)
European Union (EU) Facility Inspections
42(1)
GLP Auditing Checklist
42(17)
3 Study Design
59(22)
General Study Design Issues
61(12)
Animal Procurement and Selection
61(1)
Quarantine and Pre-Study Health Assessment
62(1)
Animal Identification
63(1)
Animal Housing
63(1)
Water and Feed
64(1)
Environmental Controls
65(1)
Randomization to Groups
66(1)
Dosing
67(1)
In-Life Evaluations
68(2)
Terminal Procedures
70(3)
Other Assessments
73(1)
Study Design Checklist
73(8)
4 Animal Welfare
81(22)
The "Guide"
84(8)
Regulations Established by the USDA Under the AWA
92(1)
Potential Conflicts Between the Animal Welfare Requirements, GLPs, and Other Study Requirements
93(1)
Animal Welfare Checklist
94(9)
5 Laboratory Selection
103(18)
Contacting and Preliminary Screening of a New Laboratory
104(4)
Meeting with a Sales and/or Technical Representative
105(3)
Visiting and Auditing a New Laboratory
108(7)
Laboratory Selection Checklist
115(6)
6 Project Proposal
121(16)
Detailed Study Outline
122(9)
Price Negotiation
131(1)
Detailed Study Outline Template
132(5)
7 Contracts and Business Ethics
137(12)
Confidentiality
137(2)
Contracts
139(3)
Maintaining Confidentiality During the Study
142(2)
Business Ethics
144(1)
Example of a Confidential Disclosure Agreement
145(4)
8 Study Protocol Preparation, Review, and Approval
149(24)
Writing the First Draft
150(1)
Reviewing the Draft Protocol
151(18)
Title Page
152(1)
Table of Contents
153(1)
Body of Protocol
153(2)
Submission of Study to Regulatory Authorities
155(1)
Test and Control Articles
155(1)
Test System
156(3)
Experimental Design
159(1)
Test and Control Article Administration
159(2)
In-Life Study Evaluations
161(3)
Scheduled Euthanasia
164(1)
Postmortem Evaluations
164(2)
Statistical Methods
166(1)
Study Reports
166(1)
Records and Specimen Retention
166(1)
Compliance with Animal Welfare Regulations
166(1)
Signatures
167(2)
Finalizing the Protocol
169(1)
Changing the Finalized Protocol
170(1)
Protocol Checklist
171(2)
9 Test Article
173(8)
Test and Control Article Synthesis and Sourcing
173(2)
Test and Control Article Characterization
175(1)
Mixtures of Test Articles
176(2)
Test Article and Mixture Receipt, Storage, and Tracking
178(1)
Additional Considerations
179(2)
10 Study Start Through End of In-Life
181(12)
Test Article and Formulations
181(1)
Acquiring Animals
182(1)
Pre-Study Meeting
183(1)
First Day of Dosing
184(2)
Protocol Deviations and Amendments
186(2)
Study Updates, Data Auditing, and GLP Compliance
188(2)
Necropsy
190(3)
11 Study Communication and Data Management
193(12)
Handling Issues That May Arise
194(1)
Data Management
195(2)
Study Reports and Archiving
197(1)
Communicating Study Results
198(5)
Study Audit Template
203(2)
12 A Study Director's Perspective on Study Monitor-Study Director Interactions
205(12)
Establishing the Working Relationship
205(1)
Setting Your Expectations
206(1)
The Study Director's Expectations of You
207(2)
Pre-Protocol Communications
209(1)
Protocol Development
210(1)
The Pre-Study Meeting
211(1)
Visiting the Laboratory
212(1)
Study Updates
213(1)
Study Issues and the Unexpected
213(2)
Test Article Issues
213(1)
Unexpected or Severe Toxicity
214(1)
Study Errors
214(1)
Reporting
215(1)
Conclusions
216(1)
13 Draft Report
217(20)
Setting Expectations
218(2)
Timeliness
218(1)
Quality
218(1)
Format
219(1)
Receiving the Draft Report
220(14)
Keeping Track of Changes and Comments
220(2)
Quality Assurance Unit Review
222(1)
Scientific and Quality Control Review
223(11)
Sending Comments to the Laboratory
234(2)
Summary
236(1)
14 Final Report, Study Close-Out, and Conclusions
237(4)
Finalizing the Report
237(2)
Amending the Final Report
239(1)
Study Close-Out
239(1)
Conclusions
240(1)
Index 241